ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2067

Understanding the Factors Influencing Time to Diagnosis in Fibromyalgia

Howard Amital1, Yaeli Bar-On2, Varda Shalev3, Dahlia Weitzman3 and Gabriel Chodick4, 1Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 2Department of Medicine E,, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, 3Medical Informatics, Maccabi Healthcare Services, Tel Aviv, Tel-Aviv, Israel, 4Medical Informatics, Healthcare Services, Tel Aviv, Tel-Aviv, Israel

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, fibromyalgia and pain, Health Care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus

Session Type: Abstract Submissions (ACR)

Background/Purpose – Fibromyalgia (FM) is a chronic debilitating disorder considered to be part of a spectrum of central sensitization syndromes. The diagnosis of FM is a complex one, affected by many different factors including stigmatization of the disease, confounders such as comorbidities and different characteristics of patient and doctor.

Aim  Investigating the time passing from initial complaints till final diagnosis by an expert rheumatologist, and delineating the patient and physician characteristics affecting that time, using the comprehensive database of a large HMO in Israel.


Methods

Using a retrospective database search we identified patients diagnosed with FM by a rheumatologist or at release from hospitalization during (“confirmed FM patients”), and sex and age matched FM-free enrollees. Different complaint patterns were tested, to ascertain time of initial complaints. The pattern with the best combination of sensitivity and specificity was applied on an FM population of all patients diagnosed by a primary physician, rheumatologist, or at release from hospitalization, during the same period (“primary physician population”). Patient and primary physician factors associated with time between initial complaints and FM diagnosis were assessed. A multilevel generalized mixed linear model with a log-linked gamma distribution was used to account for clustering of patients associated with the same primary physician

Results Our study included 4,603 “confirmed FM patients”, of whom 90.8% were women, with a mean age of 50.63 years (±11.37). The complaint pattern chosen, as time of initial complaints, comprised of  >= 4 complaints within 6 months. This pattern was found in 73.2% (1,944/2,656) of the “confirmed FM patients”, 18.4% (1,685/9,173) of the FM-free patients. Applying this pattern on the primary physician population, revealed a mean time  to diagnosis of  4.7±3.6 years. Within this time, the mean (SD) time that FMS patients were associated with the “physician at diagnosis” was 2.9±2.8. The patient factors most significantly associated with a longer time to diagnosis, were older age, female gender and low socioeconomic status. The physician characteristics most significantly associated with a longer time to diagnosis were older age, internal or general specialty vs. family specialty, and physician’s medical studies in West vs. East Europe.

Conclusion  The time to diagnosis of FM is significantly influenced by patients a and physician characteristics. This knowledge can contribute to future research and to better planning of physician education, concerning this disease.


Disclosure:

H. Amital,
None;

Y. Bar-On,
None;

V. Shalev,
None;

D. Weitzman,
None;

G. Chodick,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-the-factors-influencing-time-to-diagnosis-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology